Bio
Rumiana Tenchov is an information scientist at CAS. She earned her Ph.D. and D.Sc. degrees in biophysics from the Bulgarian Academy of Sciences. Prior to joining CAS, she was a research faculty member at the Department of Molecular Biosciences of the Northwestern University.
Drug Discovery
Enfermedades raras y enfermedades huérfanas: ¿pueden tratarse las terapias combinadas?
Cómo las terapias combinadas, como la reutilización de fármacos, la terapia celular y la terapia génica, están mejorando el tratamiento de las enfermedades raras.
Read the CAS Insights articleEmerging Science
Decoding neurodegenerative diseases like Alzheimer's, Parkinson's, and Huntington's
Uncover the latest advancements in understanding and treating neurodegenerative diseases like Alzheimer’s, Parkinson’s, and Huntington’s.
Read the CAS Insights articleDrug Discovery
Are inverse vaccines the cure for autoimmune diseases?
Sharing new research on inverse vaccines, potential new breakthroughs in treating autoimmune diseases like multiple sclerosis, type 1 diabetes and celiac disease
Read the CAS Insights articleDrug Discovery
Ending Alzheimer's: Emerging trends in biomarkers, gene therapy, and more
Biomarkers, personalized medicine and gene therapies are fueling research breakthroughs. Discover new treatments targeting genetics and protein buildup to manage this devastating disease.
Read the CAS Insights articleDrug Discovery
Can we cure Huntington's? Research trends in PolyQ and rare diseases
While no cure exists for PolyQ diseases like Huntington's, new breakthroughs, therapies, and research could change that.
Read the CAS Insights articleBiotechnology
How biomarkers unlock faster cancer detection, improving outcomes
As cancer is projected to increase, finding stronger therapeutics is more urgent. Biomarkers offer a potential solution for better diagnosis and treatment.
Read the CAS Insights articleEmerging Science
Biomarkers: The key to earlier cancer detection and patient outcomes
CAS and Excelra delved into data surrounding biomarkers and their relationship to cancer to identify key targets for future study.
Read the CAS Insights articleDrug Discovery
Unveiling the potential of the antibody drug conjugate
Since 2018, research interest in antibody-drug conjugates has increased exponentially, due to their potential in the fight against cancer.
Read the CAS Insights articleEmerging Science
Aging reimagined: Exploring the potential of anti-aging treatment strategies
Discover the latest in anti-aging treatment strategies to promote health and longevity, including stem cell therapies, hyaluronic acid, senolytics, gene therapy, and more.
Read the CAS Insights articleEmerging Science
The ultimate guide for PEGylated lipid nanoparticles
PEG immunogenicity affects the safety and efficacy of PEGylated lipid nanoparticles for drug delivery. Much work is being done to circumvent this challenge in applying these polymers.
Read the CAS Insights articleEmerging Science
Friend, not foe: Harnessing the gut microbiome for health benefits
The gut microbiome is a complex ecosystem of trillions of bacteria that live in our digestive tracts with health benefits like immunity, improved mental health, and therapeutic options.
Read the CAS Insights articleBiotechnology
The evolving exosome: from small player to rising star
A historical overview of the discovery of exosomes, key milestones in their rise, and why they will revolutionize the diagnostic and drug delivery fields in the future.
Read the CAS Insights articleSafety
Ammonium nitrate: making it safer today for a better tomorrow
Ammonium nitrate has the power to feed billions, yet when stored improperly is like a bomb waiting to happen. How can we make this fertilizer safer? Learn about emerging science, safer alternatives, and best practices for safe storage and transport.
Read the CAS Insights articleDrug Discovery
The therapeutic potential of nanotechnology beyond COVID-19
Explore lipid nanoparticles: from origins to COVID vaccines and beyond. Discover emerging trends in publications and milestones. Uncover future applications in vaccines, drug delivery, and non-therapeutic fields like agro-chemistry, cosmetics, and food science. Learn how these particles are shaping
Read the CAS Insights articleDrug Discovery
With COVID BA.5 and BA.2.75 variants, are masks back in?
The COVID pandemic revealed deficiencies in mask development and production. Innovation will be crucial in slowing the spread of new variants of the virus.
Read the CAS Insights articleDrug Discovery
Are intrinsically disordered proteins the key to treating COVID-19?
Learn about the important functions of intrinsically disordered proteins and the key role they play in COVID-19 therapy.
Read the CAS Insights articleEmerging Science
How your gut microbiome is linked to depression and anxiety
Gut microbiota, gut flora, or microbiome are the microorganisms that live in the digestive tracts of humans and other animals. While some bacteria are associated with disease, others are particularly important for many aspects of health and mental health.
Read the CAS Insights articleBiotechnology
Lipid Nanoparticles – Key Players in Cancer Treatment
Learn more about the applications of lipid nanoparticles in cancer therapy, their therapeutic benefits, and their future within nanomedicine.
Read the CAS Insights articleEmerging Science
Tackling the global vaccine distribution challenge
Newly developed microfluidic fabrication technology addresses the clinical need for scalable, precise, and reproducible solutions for vaccine production.
Read the CAS Insights articleSustainability
Can plastic eating super-enzymes solve our destructive plastic problem?
An overview of research on how microbial enzymes can break down plastics, which could otherwise take hundreds of years to degrade.
Read the CAS Insights article